Evidence map›Paper›PMID 28985224›Full record

ArticlePloS one2017

Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants.

Jan Rehker, Johanna Rodhe, Ryan R Nesbitt, Evan A Boyle, Beth K Martin, Jenny Lord, Ilker Karaca, Adam Naj, Frank Jessen, Seppo Helisalmi and 12 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. SDGCCA: Supervised Deep Generalized Canonical Correlation Analysis for Multi-Omics Integration.Journal of computational biology : a journal of computational molecular cell biology · 2022
    Article
  10. Article
  11. Review
  12. Autophagy and apoptosis cascade: which is more prominent in neuronal death?Cellular and molecular life sciences : CMLS · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 4 countries.

Jan RehkerDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States of America.ORCID http://orcid.org/0000-0001-7727-8957
Johanna RodheDepartment of Oncology-Pathology, Cancer Centrum Karolinska, Karolinska Institutet, Stockholm, Sweden.
Ryan R NesbittDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States of America.
Evan A BoyleDepartment of Genetics, Stanford University, CA, United States of America.
Beth K MartinDepartment of Genome Sciences, University of Washington, Seattle, WA, United States of America.
Jenny LordDepartment of Psychiatry, Washington University, St. Louis, MO, United States of America.
Ilker KaracaDepartment of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
Adam NajDepartment of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States of America.
Frank JessenDepartment of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
Seppo HelisalmiInstitute of Clinical Medicine-Neurology, University of Eastern Finland, Kuopio, Finland.
Hilkka SoininenInstitute of Clinical Medicine-Neurology, University of Eastern Finland, Kuopio, Finland.
Mikko HiltunenDepartment of Neurology, Kuopio University Hospital, Kuopio, Finland.
Alfredo RamirezDepartment of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany.
Martin SchererDepartment of Primary Medical Care, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Lindsay A FarrerDepartments of Medicine (Biomedical Genetics), Neurology, Ophthalmology, Epidemiology, and Biostatistics, Boston University, Boston, MA, United States of America.
Jonathan L HainesDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, United States of America.
Margaret A Pericak-VanceThe John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL, United States of America.
Wendy H RaskindDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States of America.
Carlos CruchagaDepartment of Psychiatry, Washington University, St. Louis, MO, United States of America.
Gerard D SchellenbergDepartment of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States of America.
Bertrand JosephDepartment of Oncology-Pathology, Cancer Centrum Karolinska, Karolinska Institutet, Stockholm, Sweden.
Zoran BrkanacDepartment of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States of America.
University of Washington · USUniversity of Bonn · DEUniversity of Eastern Finland · FIKarolinska Institutet · SEUniversity of Pennsylvania · USWashington University in St. Louis · USBoston University · USCase Western Reserve University · USStanford University · USUniversität Hamburg · DEUniversity of Miami · US

Funding

National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI Tammie Lee Smith Benzinger · 1985 to 2026
$69.5M
Alzheimer's Disease Genetics ConsortiumU01AG032984 · NIA · UNIVERSITY OF PENNSYLVANIA · PI SCHELLENBERG, GERARD DAVID · 2009 to 2024
$60.4M
WASHINGTON UNIVERSITY ALZHEIMERS DISEASE RESEARCH CENTERP50AG005681 · NIA · WASHINGTON UNIVERSITY · PI MORRIS, JOHN · 1985 to 2019
$52.1M
Next Generation Mendelian Genetics in Familial Alzheimer DiseaseR01AG039700 · NIA · UNIVERSITY OF WASHINGTON · PI BRKANAC, ZORAN · 2011 to 2015
$2.9M
NIA NIH HHS P01 AG003991NIA NIH HHS P50 AG005681NIA NIH HHS R01 AG039700NIA NIH HHS U01 AG016976NIA NIH HHS U01 AG032984NIA NIH HHS U24 AG021886
6 · The paper itself

Abstract

The accumulation of amyloid beta (Aβ) peptide (Amyloid cascade hypothesis), an APP protein cleavage product, is a leading hypothesis in the etiology of Alzheimer's disease (AD). In order to identify additional AD risk genes, we performed targeted sequencing and rare variant burden association study for nine candidate genes involved in the amyloid metabolism in 1886 AD cases and 1700 controls. We identified a significant variant burden association for the gene encoding caspase-8, CASP8 (p = 8.6x10-5). For two CASP8 variants, p.K148R and p.I298V, the association remained significant in a combined sample of 10,820 cases and 8,881 controls. For both variants we performed bioinformatics structural, expression and enzymatic activity studies and obtained evidence for loss of function effects. In addition to their role in amyloid processing, caspase-8 and its downstream effector caspase-3 are involved in synaptic plasticity, learning, memory and control of microglia pro-inflammatory activation and associated neurotoxicity, indicating additional mechanisms that might contribute to AD. As caspase inhibition has been proposed as a mechanism for AD treatment, our finding that AD-associated CASP8 variants reduce caspase function calls for caution and is an impetus for further studies on the role of caspases in AD and other neurodegenerative diseases.

Indexed as

AllelesGenetic VariationAlzheimer DiseaseCase-Control StudiesCaspase 8Cell Line, TumorGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHumansNeuronsCaspase 8

Identifiers

PMID28985224
PMCPMC5630132
OpenAlexW2763392697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.